Wierman appointed Theorem vice president of biopharmaceutical development
Theorem Clinical Research, a King of Prussia, Penn.-based, mid-sized provider of comprehensive clinical research and development services, has appointed Connie Wierman as vice president of biopharmaceutical development. Wierman leads the company’s oncology therapeutic focus for the biopharmaceutical business unit.
Wierman has more than 25 years of biopharmaceutical experience. She has held a number of executive posts at leading industry firms prior to joining Theorem, including vice president of clinical development in oncology for INC Research. She was also responsible for developing and leading a team of medical science liaisons in 12 territories across the U.S. for ILEX (now Sanofi-Aventis) to support the research and educational goals for oncology agents under development and those recently launched.